Učitavanje...

Adjuvant Chemotherapy for T1 Node-Positive Colon Cancers Provides Significant Survival Benefit

BACKGROUND: Contemporary treatment of node-positive (N+) colon cancer consists of adjuvant chemotherapy; however, randomized data supporting this practice were derived from lesions T2 or greater. Minimal data exist regarding the use and need for adjuvant chemotherapy in T1N+ disease. OBJECTIVE: The...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Dis Colon Rectum
Glavni autori: Ganapathi, Asvin M., Speicher, Paul J., Englum, Brian R., Castleberry, Anthony W., Migaly, John, Hsu, David S., Mantyh, Christopher R.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336178/
https://ncbi.nlm.nih.gov/pubmed/25379998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/DCR.0000000000000245
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!